Continental Investors Services’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$573K Hold
1,077
0.54% 42
2025
Q4
$722K Sell
1,077
-6
-0.6% -$4.09K 0.93% 30
2025
Q3
$688K Sell
1,083
-10
-0.9% -$6.07K 1.02% 30
2025
Q2
$586K Hold
1,093
1.05% 27
2025
Q1
$459K Hold
1,093
0.91% 31
2024
Q4
$452K Hold
1,093
0.9% 33
2024
Q3
$541K Hold
1,093
1.11% 27
2024
Q2
$533K Hold
1,093
1.19% 25
2024
Q1
$582K Hold
1,093
1.38% 22
2023
Q4
$607K Hold
1,093
1.58% 19
2023
Q3
$478K Sell
1,093
-1,093
-50% -$545K 1.45% 18
2023
Q2
$1.16M Buy
2,186
+1,093
+100% +$524K 1.37% 16
2023
Q1
$547K Hold
1,093
1.55% 15
2022
Q4
$446K Hold
1,093
1.39% 18
2022
Q3
$356K Hold
1,093
1.07% 21
2022
Q2
$383K Hold
1,093
1.12% 21
2022
Q1
$720K Hold
1,093
1.89% 14
2021
Q4
$598K Buy
+1,093
New +$686K 1.59% 15

Other funds holding IDXX

Continental Investors Services's IDXX Position: Q1 2026 in Review

Continental Investors Services held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 1,077 shares worth $573K. The position accounts for 0.54% of the portfolio, ranked #42.

Continental Investors Services first reported a position in IDXX in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.16M in Q2 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Continental Investors Services held 1,077 shares of Idexx Laboratories worth $573K as of Q1 2026.
  • Continental Investors Services left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.54% of Continental Investors Services's portfolio in Q1 2026, its #42 holding.
  • Continental Investors Services first reported a position in Idexx Laboratories in Q4 2021 and has held it in 18 quarters since.
  • Continental Investors Services's Idexx Laboratories position peaked at $1.16M in Q2 2023.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Continental Investors Services's 13F filing for Q1 2026, filed 15 May 2026.